Neuland Laboratories Limited
NSE:NEULANDLAB.NS
12363 (INR) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2009 Q4 | 2009 Q3 | 2009 Q2 | 2009 Q1 | 2008 Q3 | 2008 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3,980.318 | 3,108.438 | 4,396.017 | 3,850.097 | 3,928.283 | 4,177.486 | 3,629.939 | 3,767.731 | 2,692.5 | 2,937.055 | 2,211.699 | 2,281.3 | 2,364.698 | 2,578.476 | 2,008.867 | 2,447.047 | 2,453.918 | 2,413.928 | 2,054.238 | 1,916.419 | 2,038.437 | 1,862.177 | 1,810.075 | 1,732.736 | 1,714.795 | 1,687.408 | 1,539.575 | 1,475.077 | 1,413.644 | 1,444.289 | 1,450.067 | 855.811 | 833.927 | 792.33 | 585.152 | 575.177 | 492.375 |
| Cost of Revenue
| 2,057.245 | 1,597.557 | 3,024.552 | 1,800.199 | 1,785.915 | 1,915.805 | 1,836.048 | 2,086.589 | 1,394.345 | 1,462.023 | 1,194.896 | 1,499.707 | 1,399.942 | 1,467.194 | 1,168.178 | 1,981.405 | 1,426.569 | 1,478.994 | 1,245.677 | 1,144.25 | 1,295.989 | 1,139.809 | 1,197.899 | 1,113.486 | 1,127.507 | 1,141.237 | 1,049.333 | 825.99 | 749.544 | 909.049 | 880.123 | 402.786 | 786.336 | 726.673 | 539.102 | 451.355 | 473.098 |
| Gross Profit
| 1,923.073 | 1,510.881 | 1,371.465 | 2,049.898 | 2,142.368 | 2,261.681 | 1,793.891 | 1,681.142 | 1,298.155 | 1,475.032 | 1,016.803 | 781.593 | 964.756 | 1,111.282 | 840.689 | 465.642 | 1,027.349 | 934.934 | 808.561 | 772.169 | 742.448 | 722.368 | 612.176 | 619.25 | 587.288 | 546.171 | 490.242 | 649.087 | 664.1 | 535.24 | 569.944 | 453.025 | 47.591 | 65.657 | 46.05 | 123.822 | 19.277 |
| Gross Profit Ratio
| 0.483 | 0.486 | 0.312 | 0.532 | 0.545 | 0.541 | 0.494 | 0.446 | 0.482 | 0.502 | 0.46 | 0.343 | 0.408 | 0.431 | 0.418 | 0.19 | 0.419 | 0.387 | 0.394 | 0.403 | 0.364 | 0.388 | 0.338 | 0.357 | 0.342 | 0.324 | 0.318 | 0.44 | 0.47 | 0.371 | 0.393 | 0.529 | 0.057 | 0.083 | 0.079 | 0.215 | 0.039 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 349.917 | 0 | 0 | 0 | 277.576 | 0 | 0 | 0 | 277.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 174.114 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 49.884 | 69.638 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -60.687 | 235.948 | 155.922 | 161.269 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 227.438 | 62.114 | 71.432 | 111.326 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 0 | 0 | 300.666 | 355.844 | -423.885 | -1,229.795 | 0 | 503.683 | 0 | 0 | 0 | 446.828 | 0 | 209.566 | 0 | 321.927 | 182.329 | 188.526 | 123.806 | 336.75 | 0 | 0 | 0 | 385.967 | 0 | 0 | 0 | 166.751 | 298.062 | 227.354 | 272.595 | 0 | 0 | 0 | 0 | 56.758 | 0 |
| Other Expenses
| 1,220.093 | 1,049.348 | 0 | 0 | 1,081.151 | 2,261.681 | 1,793.891 | 0 | 1,298.155 | 1,475.032 | 1,016.803 | 0 | 964.756 | 593.199 | 840.689 | 0 | 483.103 | 430.488 | 434.939 | 0 | 742.448 | 722.368 | 612.176 | 0 | 587.288 | 546.171 | 490.242 | 0 | 500.755 | 101.193 | 92.995 | 445.224 | -15.616 | 0.565 | 0.52 | 0.245 | 0 |
| Operating Expenses
| 1,220.093 | 1,049.348 | 300.666 | 355.844 | 657.266 | 1,031.886 | 1,793.891 | 781.259 | 1,298.155 | 1,475.032 | 1,016.803 | 490.067 | 964.756 | 802.765 | 840.689 | 321.927 | 665.432 | 619.014 | 558.745 | 480.894 | 742.448 | 722.368 | 612.176 | 374.352 | 587.288 | 546.171 | 490.242 | 364.198 | 868.455 | 328.547 | 365.59 | 445.224 | -15.616 | 0.565 | 0.52 | 57.003 | 0 |
| Operating Income
| 702.98 | 461.533 | 1,070.799 | 904.54 | 1,061.217 | 1,260.273 | 833.344 | 1,216.642 | 407.469 | 561.249 | 158.054 | 317.207 | 196.576 | 308.517 | 138.602 | 168.681 | 361.917 | 315.92 | 249.816 | 254.899 | 203.419 | 166.674 | 111.095 | 174.811 | 86.071 | 88.837 | 34.755 | 323.167 | -204.355 | 206.693 | 204.355 | 7.801 | 63.207 | 65.092 | 45.53 | 66.819 | 19.277 |
| Operating Income Ratio
| 0.177 | 0.148 | 0.244 | 0.235 | 0.27 | 0.302 | 0.23 | 0.323 | 0.151 | 0.191 | 0.071 | 0.139 | 0.083 | 0.12 | 0.069 | 0.069 | 0.147 | 0.131 | 0.122 | 0.133 | 0.1 | 0.09 | 0.061 | 0.101 | 0.05 | 0.053 | 0.023 | 0.219 | -0.145 | 0.143 | 0.141 | 0.009 | 0.076 | 0.082 | 0.078 | 0.116 | 0.039 |
| Total Other Income Expenses Net
| 574.669 | 32.693 | 227.621 | 17.48 | -16.407 | -44.333 | -1.749 | -115.006 | -18.118 | -29.363 | -23.463 | -74.454 | -14.217 | -32.736 | -17.87 | 75.22 | -42.44 | -29.064 | -46.714 | -82.919 | -46.701 | -42.132 | -35.11 | -93.106 | -25.946 | -34.353 | -27.699 | -48.31 | 301.539 | -52.796 | -54.447 | 66.264 | -37.815 | -34.89 | -31.849 | -31.998 | -6.899 |
| Income Before Tax
| 1,277.649 | 494.226 | 1,298.42 | 922.02 | 1,044.81 | 1,215.94 | 831.595 | 1,101.636 | 389.351 | 531.886 | 134.591 | 242.753 | 182.359 | 275.781 | 120.732 | 243.901 | 319.477 | 286.856 | 203.102 | 171.98 | 156.718 | 124.542 | 75.985 | 81.705 | 60.125 | 54.484 | 7.056 | 274.858 | 97.185 | 153.897 | 149.908 | 74.065 | 25.392 | 30.202 | 13.681 | 34.821 | 12.378 |
| Income Before Tax Ratio
| 0.321 | 0.159 | 0.295 | 0.239 | 0.266 | 0.291 | 0.229 | 0.292 | 0.145 | 0.181 | 0.061 | 0.106 | 0.077 | 0.107 | 0.06 | 0.1 | 0.13 | 0.119 | 0.099 | 0.09 | 0.077 | 0.067 | 0.042 | 0.047 | 0.035 | 0.032 | 0.005 | 0.186 | 0.069 | 0.107 | 0.103 | 0.087 | 0.03 | 0.038 | 0.023 | 0.061 | 0.025 |
| Income Tax Expense
| 261.781 | 165.799 | 319.693 | 246.401 | 230.908 | 323.462 | 212.805 | 256.197 | 83.869 | 147.289 | 34.933 | 24.945 | 53.003 | 72.07 | 33.387 | 70.975 | 52.125 | 72.456 | 51.472 | 264.937 | 45.614 | 37.655 | 18.914 | 15.399 | 13.209 | 8.974 | 1.375 | 70.727 | 33.67 | 50.01 | 49.408 | -7.86 | 7 | 21.499 | 3.5 | 5.162 | -0.05 |
| Net Income
| 1,015.868 | 328.427 | 978.727 | 675.619 | 813.902 | 892.478 | 618.79 | 845.439 | 305.482 | 384.597 | 99.658 | 217.807 | 129.356 | 203.711 | 87.345 | 172.926 | 267.352 | 214.4 | 151.63 | -92.957 | 111.104 | 86.887 | 57.071 | 66.306 | 46.916 | 45.51 | 5.681 | 204.131 | 63.515 | 103.887 | 100.5 | 81.955 | 18.392 | 8.703 | 10.181 | 40.471 | 12.428 |
| Net Income Ratio
| 0.255 | 0.106 | 0.223 | 0.175 | 0.207 | 0.214 | 0.17 | 0.224 | 0.113 | 0.131 | 0.045 | 0.095 | 0.055 | 0.079 | 0.043 | 0.071 | 0.109 | 0.089 | 0.074 | -0.049 | 0.055 | 0.047 | 0.032 | 0.038 | 0.027 | 0.027 | 0.004 | 0.138 | 0.045 | 0.072 | 0.069 | 0.096 | 0.022 | 0.011 | 0.017 | 0.07 | 0.025 |
| EPS
| 79.18 | 25.6 | 76.28 | 52.66 | 63.44 | 69.56 | 48.23 | 65.9 | 23.81 | 29.97 | 7.77 | 16.98 | 10.08 | 15.88 | 6.81 | 13.48 | 20.84 | 16.71 | 11.82 | -7.25 | 8.66 | 6.77 | 4.45 | 5.17 | 3.66 | 3.55 | 0.44 | 22.98 | 7.15 | 11.69 | 11.31 | 12.34 | 2.82 | 1.33 | 1.56 | 6.19 | 1.9 |
| EPS Diluted
| 79.18 | 25.6 | 76.28 | 52.66 | 63.44 | 69.56 | 48.23 | 65.9 | 23.81 | 29.97 | 7.77 | 16.97 | 10.08 | 15.88 | 6.81 | 13.48 | 20.84 | 16.71 | 11.82 | -7.24 | 8.66 | 6.77 | 4.45 | 5.17 | 3.66 | 3.55 | 0.44 | 22.98 | 7.15 | 11.69 | 11.31 | 12.34 | 2.82 | 1.33 | 1.56 | 6.19 | 1.9 |
| EBITDA
| 1,462.819 | 665.602 | 1,487.924 | 1,093.506 | 1,233.661 | 1,405.35 | 989.591 | 1,231.411 | 550.163 | 695.359 | 291.165 | 355.381 | 343.325 | 431.207 | 277.449 | 340.321 | 467.954 | 414.675 | 345.414 | 264.732 | 291.825 | 255.189 | 191.812 | 140.568 | 163.657 | 154.392 | 102.499 | 369.901 | 188.687 | 245.259 | 242.92 | 135.19 | 75.373 | 80.477 | 57.539 | 79.415 | 45.947 |
| EBITDA Ratio
| 0.368 | 0.214 | 0.338 | 0.284 | 0.314 | 0.336 | 0.273 | 0.327 | 0.204 | 0.237 | 0.132 | 0.156 | 0.145 | 0.167 | 0.138 | 0.139 | 0.191 | 0.172 | 0.168 | 0.138 | 0.143 | 0.137 | 0.106 | 0.081 | 0.095 | 0.091 | 0.067 | 0.251 | 0.133 | 0.17 | 0.168 | 0.158 | 0.09 | 0.102 | 0.098 | 0.138 | 0.093 |